The invention discloses application of a Cslnc924
gene in diagnosis or prevention and treatment of
tea tree anthracnose, and relates to the technical field of prevention and treatment of
tea tree anthracnose. The Cslnc924
gene is used for promoting the expression of the Cslnc924
gene so as to enhance the resistance of tea trees to
colletotrichum gloeosporioides, and the cDNA full-length sequence of the Cslnc924 gene is as shown in SEQ ID No.1. The method has the beneficial effects that on the basis of an
agrobacterium tumefaciens-mediated transient overexpression technology and an antisense
oligonucleotide-mediated
gene silencing technology, the Cslnc924 gene is overexpressed and silenced on
tea tree leaves respectively, and an anthrax
inoculation test is carried out. Results show that when Cslnc924 is overexpressed, compared with a control group, CsmiR390 is remarkably up-regulated, downstream CsARFs (CsARF2.1, CsARF2.2, CsARF3 and CsARF4.1) of CsmiR390 are remarkably down-regulated, at the moment, resistance of tea trees to
colletotrichum gloeosporioides is enhanced, and the area of
disease spots is remarkably reduced.